Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
36.65
-0.46 (-1.24%)
Jul 10, 2026, 4:00 PM EDT - Market closed

HRTS Holdings Information

HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 11.76%, UnitedHealth Group at 5.62%, Novo Nordisk at 5.19%, Thermo Fisher Scientific at 4.07%, and Merck & Co. at 3.92%.

Total Holdings
45
Top 10 Percentage
48.79%
Asset Class
Equity
ETF Category
Health
Assets
52.14M
PE Ratio
21.35

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company11.76%5,343
2UNHUnitedHealth Group Incorporated5.62%7,195
3CPH: NOVO.BNovo Nordisk A/S5.19%58,669
4TMOThermo Fisher Scientific Inc.4.07%4,289
5MRKMerck & Co., Inc.3.92%17,317
6RHHBYRoche Holding AG3.90%41,422
7JNJJohnson & Johnson3.83%8,166
8LON: AZNAstraZeneca PLC3.57%11,030
9CYTKCytokinetics, Incorporated3.49%22,413
10RVMDRevolution Medicines, Inc.3.44%9,951
11SWX: NOVNNovartis AG3.20%11,473
12GILDGilead Sciences, Inc.3.19%13,087
13BBIOBridgeBio Pharma, Inc.2.92%17,908
14VRTXVertex Pharmaceuticals Incorporated2.77%3,079
15DHRDanaher Corporation2.75%7,756
16ABTAbbott Laboratories2.66%15,601
17ABBVAbbVie Inc.2.55%5,640
18ISRGIntuitive Surgical, Inc.2.38%3,200
19BMYBristol-Myers Squibb Company1.96%18,689
20MDTMedtronic plc1.94%13,029
21AMGNAmgen Inc.1.91%2,908
22TEVATeva Pharmaceutical Industries Limited1.79%29,873
23DXCMDexCom, Inc.1.76%13,334
24MCKMcKesson Corporation1.70%1,182
25REGNRegeneron Pharmaceuticals, Inc.1.68%1,390
Showing 25 of 45 holdings
Subscribe to see the full list
As of Jul 8, 2026